Hou P-F, Zhu L-J, Pan Y, Sun X-C, Pu J
Department of Clinical Laboratory, Lianshui County People's Hospital, Lianshui, China.
Department of Radiation Oncology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Cancer Radiother. 2020 Feb;24(1):81-84. doi: 10.1016/j.canrad.2019.07.160. Epub 2020 Feb 8.
Radiation therapy (RT) is an effective treatment for cancer. Approximately, 70% of cancer patients receive RT in China. The immune-modulating effect of radiation therapy have gained considerable interest in recent years and there have been multiple reports of synergy between radiation and immunotherapy. Regulatory T cells (Tregs) are a group of T cell subsets with immunosuppressive function, which is correlated with cancer. Tregs are involved in the pathogenesis, development, treatment and prognosis of tumors by cell-cell contact, cytokines, and cell metabolism. Based on the immunological characteristics of Tregs, this article reviews the interaction between RT and immune molecules, aiming to provide new ideas for RT combined with immunotherapy.
放射治疗(RT)是一种有效的癌症治疗方法。在中国,约70%的癌症患者接受放射治疗。近年来,放射治疗的免疫调节作用引起了广泛关注,并且有多项关于放射治疗与免疫治疗协同作用的报道。调节性T细胞(Tregs)是一组具有免疫抑制功能的T细胞亚群,与癌症相关。Tregs通过细胞间接触、细胞因子和细胞代谢参与肿瘤的发病机制、发展、治疗和预后。基于Tregs的免疫学特性,本文综述了放射治疗与免疫分子之间的相互作用,旨在为放射治疗联合免疫治疗提供新思路。